COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data.

ABSTRACT:

Background

The COVID-19 pandemic profoundly disrupted the delivery of medical care. It remains unclear whether individuals diagnosed with new onset disease during the pandemic were less likely to initiate treatments after diagnosis. We sought to evaluate changes in the treatment initiation of patients newly diagnosed with atrial fibrillation (AF) after the onset of the COVID-19 pandemic.

Methods

In this retrospective cohort study, we identified individuals with incident AF from 01/01/2016-09/30/2021 using Optum's de-identified Clinformatics® Data Mart Database. The primary outcome was initiation of oral anticoagulation (OAC) within 30 days of AF diagnosis. Secondary outcomes included initiation of OAC within 180 days of diagnosis, initiation of warfarin, direct oral anticoag

SUBMITTER: Yang L 

PROVIDER: S-EPMC10704685 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature